Who
Jan Johannessen
Director
Company insider
Files Form 4 as: Director, Twist Bioscience; Senior Vice President, CFO, Lattice Semiconductor.
In numbers
- Trades disclosed
- 42
- Buys
- 0
- Sells
- 9
- Bought
- $0
- Sold
- $3.6M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 1 Aug 2006
- Last trade
- 12 May 2026
- Last filed
- 14 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 May 2026filed 14 May 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Code M | $168K12,000 at $14.00 | filing |
| 12 May 2026filed 14 May 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $673K12,000 at $56.12 | filing |
| 12 May 2026filed 14 May 2026 | TWST Twist Bioscienceoption or derivative · Genomics & Gene Editing | SEC FORM 4 Code M | —12,000 at $0.00 | filing |
| 12 May 2026filed 14 May 2026 | TWST Twist Bioscienceoption or derivative · Genomics & Gene Editing | SEC FORM 4 Code M | —12,000 at $0.00 | filing |
| 12 May 2026filed 14 May 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Code M | $168K12,000 at $14.00 | filing |
| 12 May 2026filed 14 May 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $673K12,000 at $56.12 | filing |
| 6 Feb 2026filed 9 Feb 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $105K2,200 at $47.91 | filing |
| 6 Feb 2026filed 9 Feb 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $105K2,200 at $47.91 | filing |
| 5 Feb 2026filed 9 Feb 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Code A | —5,095 at $0.00 | filing |
| 5 Feb 2026filed 9 Feb 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Code A | —5,095 at $0.00 | filing |
| 18 Nov 2025filed 20 Nov 2025 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $174K7,044 at $24.77 | filing |
| 5 Feb 2025filed 7 Feb 2025 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Code A | —4,472 at $0.00 | filing |
| 6 Feb 2024filed 9 Feb 2024 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Code A | —5,815 at $0.00 | filing |
| 9 Feb 2023filed 13 Feb 2023 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $46K1,732 at $26.46 | filing |
| 7 Feb 2023filed 9 Feb 2023 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Code A | —8,212 at $0.00 | filing |
| 16 Feb 2022filed 18 Feb 2022 | TWST Twist Bioscienceoption or derivative · Genomics & Gene Editing | SEC FORM 4 Code M | —5,000 at $0.00 | filing |
| 16 Feb 2022filed 18 Feb 2022 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Code M | $70K5,000 at $14.00 | filing |
| 16 Feb 2022filed 18 Feb 2022 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $296K5,000 at $59.20 | filing |
| 8 Feb 2022filed 10 Feb 2022 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Code A | —3,491 at $0.00 | filing |
| 4 Feb 2022filed 8 Feb 2022 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $15K253 at $58.88 | filing |
News
Twist Bioscience (NASDAQ:TWST) versus Quanterix (NASDAQ:QTRX) Financial AnalysisTWST · tickerreport.com · 15 Oct 2026
0 headlines in the last 90 days name Jan Johannessen; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.